23 insiders reported 112 Form 4 transactions for Acrivon Therapeutics, Inc. (ACRV) over the past 18 months (most recent 2026-05-20). Recent activity: Devroe Eric (Chief Operating Officer) Buy 72,981 shares, Blume-Jensen Peter (President and CEO) Buy 72,706 shares, Masson Kristina (EVP - Business Operations) Buy 180,095 shares, Peterson Katharine (Chief Accounting Officer) Buy 14,227 shares, Palani Santhosh (Director) Buy 9,366 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Devroe Eric | Chief Operating Officer | Buy | 72,981 | $0 |
| 2026-05-20 | Blume-Jensen Peter | President and CEO | Buy | 72,706 | $0 |
| 2026-05-20 | Masson Kristina | EVP - Business Operations | Buy | 180,095 | $0 |
| 2026-05-20 | Peterson Katharine | Chief Accounting Officer | Buy | 14,227 | $0 |
| 2026-05-20 | Palani Santhosh | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Levy Adam D. | Chief Financial Officer | Buy | 46,167 | $0 |
| 2026-05-20 | Gamelin Erick | Chief Development Officer | Buy | 38,584 | $0 |
| 2026-05-20 | Masson Kristina | EVP - Business Operations | Buy | 72,706 | $0 |
| 2026-05-20 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Kolchinsky Peter | Director | Buy | 9,366 | $0 |
| 2026-05-20 | TOMSICEK MICHAEL JOHN | Director | Buy | 9,366 | $0 |
| 2026-05-20 | BAUM CHARLES M | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Mirza Mansoor Raza | Chief Medical Officer | Buy | 38,817 | $0 |
| 2026-05-20 | Shacham Sharon | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Shah Rajeev M. | Director | Buy | 9,366 | $0 |
| 2026-05-20 | DiRocco Derek | Director | Buy | 9,366 | $0 |
| 2026-05-20 | RA Capital Nexus Fund II, L.P. | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Miller Mary | Chief Legal Officer | Buy | 49,830 | $0 |
| 2026-05-20 | Magovcevic-Liebisch Ivana | Director | Buy | 9,366 | $0 |
| 2026-05-20 | Blume-Jensen Peter | President and CEO | Buy | 180,095 | $0 |
| 2026-05-20 | RA Capital Healthcare Fund LP | Director | Buy | 9,366 | $0 |
| 2026-05-18 | Blume-Jensen Peter | President and CEO | Sell | 1,253 | $2,406 |
| 2026-05-18 | Miller Mary | Chief Legal Officer | Sell | 184 | $353 |
| 2026-05-18 | Peterson Katharine | Chief Accounting Officer | Sell | 99 | $190 |
| 2026-05-18 | Devroe Eric | Chief Operating Officer | Sell | 613 | $1,177 |
Source: SEC Form 4 filings · as of 2026-05-20